All Companies
Ticker BIIB
SEC data is missing this company's latest quarter
You reached the page — here's exactly what BIIB is, and why it's out of scope for now.
What this ticker is
BIIB
Biogen Inc.
NASDAQ
Healthcare
Drug Manufacturers - General
United States
Mkt cap $32.6B
Biogen Inc. is a biotechnology company focused on discovering, developing, and delivering therapies for serious neurological, neurodegenerative, and rare diseases. Biogen’s current portfolio includes treatments for multiple sclerosis, Alzheimer’s disease, spinal muscular atrophy, amyotrophic lateral sclerosis, and Friedreich’s ataxia, along with therapies a…
Why we can't analyze it yet
SEC data is missing this company's latest quarter: the SEC's companyfacts (refetched) ends at 2026-03-31 while its index lists a statement period 2026-06-30 — the SEC's aggregation omitted the filing; not recoverable from any archive we read Found by the Foundation Sweep four-quarter pass 2026-09-11; held under the four-quarter coverage policy (2026-09-11) and released automatically once the pass resolves it.
We no longer service this ticker — but here's our last report on it
Generated Aug 26, 2026.
It may be stale or unverified at this point — read it as a historical snapshot, not a current view.
Open last report
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
sec_omission